Pengembangan Vaksin Merah Putih Capai 55 Persen

Summary

Indonesia's 'Vaksin Merah Putih' (Red and White Vaccine) has reached 50% development, with projections for clinical trials to begin by March 2021. The vaccine is being developed to meet the nation's urgent health needs, with protein production in mammalian cells showing promising results. Additionally, Sinovac's vaccine is undergoing Phase 3 trials in Indonesia. Public willingness to receive the vaccine is growing, while health protocols like mask-wearing and social distancing continue to be emphasized. The vaccines aim to ensure safety, speed, and effectiveness in curbing the COVID-19 pandemic.

Takeaways

• 😀 The development of Indonesia's 'Merah Putih' vaccine has reached 50% completion and will be handed over to PT Biofarma in February or March 2021.
• 😀 The 'Merah Putih' vaccine is currently in the recombinant protein production stage, with proteins like Spike and nucleocapsid being tested in mammalian cells.
• 😀 45% of Indonesians have expressed their willingness to receive the 'Merah Putih' vaccine.
• 😀 The vaccine development process has a target timeline of about 12 months, with completion expected around March 2021.
• 😀 If preclinical trials are successful, clinical trials are expected to conclude by the end of 2021.
• 😀 In parallel, the Sinovac vaccine is undergoing Phase 3 clinical trials in Bandung with 1,620 adult participants.
• 😀 The Sinovac vaccine has already been tested in countries such as Brazil, Turkey, and the UAE.
• 😀 Clinical trials for the Sinovac vaccine have been successful, with results expected to be used in Indonesia soon.
• 😀 The public is urged to continue following health protocols, including wearing masks, maintaining distance, and washing hands, to prevent COVID-19 transmission.
• 😀 Despite progress, the vaccine distribution process will take time, and the government emphasizes that there are several stages left before mass distribution.

Q & A

What is the current progress of the Merah Putih vaccine development?

The development of the Merah Putih vaccine has reached 55% completion. The vaccine is expected to be handed over to PT Biofarma by February or March 2021.

How many people are involved in the ongoing vaccine clinical trials?

The Innova vaccine clinical trials have involved 1,620 subjects, and they are currently awaiting results.

What is the target date for the completion of the Merah Putih vaccine?

The Merah Putih vaccine is expected to be ready for distribution by March 2021, with clinical trials expected to complete by the end of 2021.

What phase is the Merah Putih vaccine currently in?

The Merah Putih vaccine is in the stage of producing recombinant proteins, specifically targeting Spike protein and nucleocapsid protein, which are being inserted into mammalian cells for testing.

What percentage of the Indonesian population has expressed willingness to receive the Merah Putih vaccine?

Currently, 45% of the Indonesian population has expressed their willingness to receive the Merah Putih vaccine.

What happens after the vaccine is handed over to PT Biofarma?

Once the Merah Putih vaccine is handed over to PT Biofarma, clinical trials are expected to be completed by the end of 2021.

What is the status of the Sinovac vaccine in Indonesia?

The Sinovac vaccine is currently in phase 3 clinical trials in Bandung, involving 1,620 adult participants, with results still pending.

Is the Sinovac vaccine being tested in other countries besides Indonesia?

Yes, the Sinovac vaccine has been tested in several countries, including Brazil, Turkey, and the UAE.

What steps are being taken to ensure vaccine safety?

The vaccine trials are closely monitored, and researchers, such as Kusnandir Umild from Unpad, guarantee that the vaccines being tested are safe. Once the clinical trials are completed, the vaccines will be used in Indonesia.

What measures should people continue to follow during vaccine development?

Despite the vaccine development progress, people are advised to continue adhering to health protocols, including wearing masks, maintaining social distancing, and washing hands to prevent the spread of COVID-19.